Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
Welcome Back Simo Jääskeläinen!
Medaffcon welcomes back its first ever recruitment!
In 2011 Simo Jääskeläinen was Medaffcon’s first recruitment. A couple of years ago Simo spread his wings to tackle new challenges and further develop his experience in different Market Access positions.
Simo has more than 12 years of experience from the pharmaceutical industry.
Now in June, to our great joy, Simo returned to Medaffcon, taking on the responsibility of leading our Market Access team. We are glad to welcome Simo back “home”!
At Medaffcon, this experience from the pharmaceutical and medtech industries, already exceeds 130 working years, all of which is harnessed to find the best solutions for our customers. Due to our experience and over 400 Medaffcon projects, we understand our customers’ playing field probably better than any of our competitors!
